Accord BioPharma receives FDA OK for 420 mg strength of HercessiThe 420 mg strength of Hercessi, a biosimilar to Herceptin, is used to treat HER2-overexpressing breast and gastric or gastroesophageal junction adenocarcinoma. Gilead signs agreements with 6 generic manufacturers for Lenacapavir The generic companies that will manufacture and supply Lenacapavir to 120 countries are Dr. Reddy’s, Emcure, Eva Pharma, Ferozsons Laboratories, Hetero and Mylan, a subsidiary of Viatris Teva intros generic Sandostatin LAR Depot Octreotide acetate for injectable suspension is indicated to treat acromegaly and severe diarrhea for carcinoid syndrome. Fresenius Kabi, Formycon receive FDA nod for Stelara biosimilar Otulfi is approved for the treatment of Crohn’s disease, ulcerative colitis, moderate to severe plaque psoriasis and active psoriatic arthritis. Premier, Long Grove join forces to increase supply of norepinephrine IV bags Norepinephrine IV bags have experienced ongoing product availability issues over the past five years as demand has outpaced supply. Hikma celebrates 40 years of Hatch-Waxman drug savings The Drug Price Competition and Patent Term Restoration Act of 1984 established the modern system for regulating generic drugs in the United States. Camber touts readiness for DSCSA compliance Camber said that it integrates advanced technology to maintain compliance and uphold the highest product safety standards. Alembic receives FDA nod for 2 generics The FDA has approved Alembic's generic Albenza and generic Invega. AAM taps John Murphy as president and CEO Murphy most recently served as the chief policy officer at the Biotechnology Innovation Organization. Avenacy intros generic Reglan Metoclopramide injection is indicated for the relief of symptoms associated with diabetic gastroparesis. First Previous 21 22 23 24 25 Next Last
